SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-112015
Filing Date
2016-07-07
Accepted
2016-07-07 16:43:06
Documents
1
Period of Report
2016-06-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v443796_4.html 4  
1 OWNERSHIP DOCUMENT v443796_4.xml 4 3317
  Complete submission text file 0001144204-16-112015.txt   4779
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 155 WALNUT STREET ENGLEWOOD NJ 07631
Business Address
RICE YEHUDA MICHAEL (Reporting) CIK: 0001674405 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35076 | Film No.: 161756996